Here are eight dental company expansions and investments Becker’s has reported on in 10 days. 1. Davary & Smith Oral & Maxillofacial Surgery & Dental Implant Center has opened in Sterling, Va. The ...

With over 8.9 million micromirrors, TI’s DLP991UUV digital micromirror device (DMD) enables maskless digital lithography for advanced packaging. Its 4096×2176 micromirror array, 5.4-µm pitch, and ...

Duchenne muscular dystrophy (DMD) causes muscle weakness that becomes more severe over time. While there is no cure, treatments can help slow the progression and manage symptoms and complications.

Capricor Therapeutics is advancing deramiocel (CAP-1002) for DMD cardiomyopathy, with a BLA resubmission and HOPE-3 topline data expected by 2026. CAPR's therapy addresses a critical unmet need in non ...

Duchenne muscular dystrophy (DMD) occurs as a result of genetic changes on the X chromosome. If someone has a gene change that can cause DMD, their children may inherit that change. DMD is a ...

There is no cure for DMD, but treatments can slow the progression of the disease and help improve quality of life. Duchenne muscular dystrophy (DMD) is a chronic condition that causes a gradual loss ...

Tailwind Capital has made an investment in DMD Systems Recovery, a Tempe, Arizona-based IT asset disposition solutions provider. No financial terms were disclosed. The capital infusion will be used by ...

Sarepta Therapeutics Inc. investors finally got some good news, but analysts worry that it could still take a while for doctors and patients to again feel comfortable using the biotechnology company’s ...

Following a review of safety data in the ambulatory DMD population, the FDA had recommended the removal of the voluntary hold for these patients. The Food and Drug Administration (FDA) is allowing ...

The U.S. FDA has granted Precision Biosciences Inc.’s PBGENE-DMD orphan drug designation for the treatment of Duchenne muscular dystrophy (DMD). PBGENE-DMD uses two complementary Arcus nucleases ...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing ...

Sarepta Therapeutics said it has temporarily suspended shipments of Elevidys ® (delandistrogene moxeparvovec-rokl) for infusion in non-ambulatory patients following the second death in three months of ...